• Joost P H Drenth, Rene H M Te Morsche, Sahar Mansour, and Peter S Mortimer.
• Division of Gastroenterology and Hepatology, Department of Medicine, University Medical Center St Radboud, PO Box 9101, 6500 HB Nijmegen, the Netherlands. JoostPHDrenth@CS.com
• Arch Dermatol. 2008 Mar 1;144(3):320-4.

ObjectivesTo elucidate the rate of missense mutations in the SCN9A gene (which encodes sodium channel Na(v)1.7) (OMIM 603415) among patients with primary erythermalgia and to examine the possibility that other sodium channels can cause the disease.DesignCase series.SettingDepartment of Medicine, Radboud University Nijmegen, the Netherlands.ParticipantsSix patients with sporadic and 9 with unique familial primary erythermalgia. Interventions Questionnaire to determine clinical profile and sequencing of all coding exons from SCN9A and those of SCN10A (OMIM 604427) and SCN11A (OMIM 604385) in 2 selected cases with a clear family history of the disease.Main Outcome MeasuresDetection of SCN9A mutation.ResultsWe identified 1 patient with an SCN9A mutation. This mutation (I848T) has been associated with primary erythermalgia. Sequencing of 2 other candidate genes did not show mutations in 2 patients with familial primary erythermalgia.ConclusionsThe Na(v)1.7 voltage-gated sodium channels are related to syndromes of altered nociception. We detected a low SCN9A mutation rate in patients with primary erythermalgia, suggesting that pain syndromes in the skin may have a polygenic basis.

26 keywords...

hide…